|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.02 USD | +0.99% |
|
-4.67% | -62.64% |
| Mar. 15 | North American Morning Briefing : Inflation Worries Continue to Weigh on Mood | DJ |
| Mar. 14 | Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan 16 (Reuters) - Allakos Inc said on Tuesday that it plans to discontinue studies testing its experimental skin disease drug after it failed two mid-stage studies.
The company also said it plans to cut 50% of its workforce as part of a restructuring. (Reporting by Sneha S K; Editing by Sonia Cheema)
| 1st Jan change | Capi. | |
|---|---|---|
| -62.64% | 90.32M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ALLAKOS INC. 
